Epidemiological Features and Economic Burden of Guillain-Barré Syndrome in South Korea: A Nationwide Population-Based Study
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background and Purpose Guillain-Barré syndrome (GBS) is rare, but its symptoms are severe and they occasionally lead to long-term disability. Country-specific epidemiological evidence is useful for detecting potential problems at the population level. This study investigated the epidemiological and economic characteristics of GBS in South Korea. Methods The Korean National Health Insurance Service claims data from 2010 to 2016 were used to identify incident cases as newly hospitalized patients with a primary diagnosis of GBS (the 10th revision of the International Classification Disease code of G61.0). New cases were defined as patients not having claim records for GBS within one year prior to the hospital admission for GBS. Results The incidence rate increased by 45.6% between 2010 and 2016, from 1.28 to 1.82 per 100,000 population. All age groups other than <20 years showed increasing trends. The incidence rate was highest in those aged 65 years to 74 years. Approximately 72% of the incident GBS cases had antecedent infection within 42 days before GBS was diagnosed. Children younger than 10 years constituted the highest proportion of antecedent infections (93.7%). The average length of stay per GBS hospitalization was 33.5 days. Patients had an average of 7.48 outpatient visits for GBS treatment per year. The economic burden from a societal perspective of treating GBS during the first year was USD 16,428. Conclusions The increasing incidence trend and substantial economic burden of GBS strongly advocate the development of effective strategies for preventing and managing GBS.
Abstract
Background and Purpose Guillain-Barré syndrome (GBS) is rare, but its symptoms are severe and they occasionally lead to long-term disability. Country-specific epidemiological evidence is useful for detecting potential problems at the population level. This study investigated the epidemiological and economic characteristics of GBS in South Korea. Methods The Korean National Health Insurance Service claims data from 2010 to 2016 were used to identify incident cases as newly hospitalized patients with a primary diagnosis of GBS (the 10th revision of the International Classification Disease code of G61.0). New cases were defined as patients not having claim records for GBS within one year prior to the hospital admission for GBS. Results The incidence rate increased by 45.6% between 2010 and 2016, from 1.28 to 1.82 per 100,000 population. All age groups other than <20 years showed increasing trends. The incidence rate was highest in those aged 65 years to 74 years. Approximately 72% of the incident GBS cases had antecedent infection within 42 days before GBS was diagnosed. Children younger than 10 years constituted the highest proportion of antecedent infections (93.7%). The average length of stay per GBS hospitalization was 33.5 days. Patients had an average of 7.48 outpatient visits for GBS treatment per year. The economic burden from a societal perspective of treating GBS during the first year was USD 16,428. Conclusions The increasing incidence trend and substantial economic burden of GBS strongly advocate the development of effective strategies for preventing and managing GBS.
참고문헌 (41)
- Ho TW, "Patterns of recovery in the Guillain-Barre syndromes", Neurology, 48, pp.695~700 (1997)
- Willison HJ, "Guillain-Barré syndrome", Lancet, 388, pp.717~727 (2016)
- Hughes RA, "Guillain-Barré syndrome", Lancet, 366, pp.1653~1666 (2005)
- Bersano A, "Long term disability and social status change after Guillain-Barré syndrome", J Neurol, 253, pp.214~218 (2006)
- Hadden RD, "Preceding infections, immune factors, and outcome in Guillain-Barré syndrome", Neurology, 56, pp.758~765 (2001)
- Jacobs BC, "The spectrum of antecedent infections in Guillain-Barré syndrome : a case-control study", Neurology, 51, pp.1110~1115 (1998)
- González-Suárez I, "Guillain-Barré syndrome : natural history and prognostic factors : a retrospective review of 106 cases", BMC Neurol, 13, pp.95~ (2013)
- Jackson BR, "Binational outbreak of Guillain-Barré syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011", Epidemiol Infect, 142, pp.1089~1099 (2014)
- Souayah N, "Guillain-Barré syndrome after Gardasil vaccination : data from vaccine adverse event reporting system 2006-2009", Vaccine, 29, pp.886~889 (2011)
- Tam CC, "Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database", PLoS One, 2, pp.e344~ (2007)
- Sejvar JJ, "Population incidence of Guillain-Barré syndrome : a systematic review and meta-analysis", Neuroepidemiology, 36, pp.123~133 (2011)
- Ng KK, "Management and outcome of severe Guillain-Barré syndrome", QJM, 88, pp.243~250 (1995)
- Benedetti MD, "A multicentric prospective incidence study of GuillainBarré syndrome in Italy. The ITANG Study", Neuroepidemiology, 45, pp.90~99 (2015)
- "Population Projections for Korea: population trends and projections of the world and Korea"[URL]
- 김종국, "Prevalence of Anti-Ganglioside Antibodies and Their Clinical Correlates with Guillain-Barré Syndrome in Korea: A Nationwide Multicenter Study", Journal of Clinical Neurology, 10(2), pp.94~100 (2014), 대한신경과학회[DOI]
- McGrogan A, "The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review", Neuroepidemiology, 32, pp.150~163 (2009)
- Huang WC, "A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan", Neuroepidemiology, 44, pp.249~254 (2015)
- Cheng Q, "Distinct pattern of age-specific incidence of Guillain-Barré syndrome in Harbin, China", J Neurol, 249, pp.25~32 (2002)
- Kusumi M, "Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan", Psychiatry Clin Neurosci, 49, pp.169~174 (1995)
- Bae JS, "GuillainBarré syndrome in Asia", J Neurol Neurosurg Psychiatry, 85, pp.907~913 (2014)
- Cho H, "Prevalence and predictors of potentially inappropriate prescribing of central nervous system and psychotropic drugs among elderly patients : a national population study in Korea", Arch Gerontol Geriatr, 74, pp.1~8 (2018)
- Chiò A, "Guillain-Barré syndrome : a prospective, population-based incidence and outcome survey", Neurology, 60, pp.1146~1150 (2003)
- Van Koningsveld R, "Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands", Neurology, 54, pp.620~625 (2000)
- Kwong JC, "Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters : a self-controlled study", Lancet Infect Dis, 13, pp.769~776 (2013)
- Kang JH, "Increased risk of Guillain-Barré syndrome following recent herpes zoster : a population-based study across Taiwan", Clin Infect Dis, 51, pp.525~530 (2010)
- Mori M, "Haemophilus influenzae infection and Guillain-Barré syndrome", Brain, 123(Pt 10), pp.2171~2178 (2000)
- Yuki N, "Guillain-Barré syndrome", N Engl J Med, 366, pp.2294~2304 (2012)
- The 2017 survey of medical expenses for medical services frequently provided, "National Health Insurance Service", National Health Insurance Service, ~ (2018)
- "The Third Korea National Health and Nutrition Examination Survey (KNHANES III)"[URL]
- Alshekhlee A, "Guillain-Barré syndrome : incidence and mortality rates in US hospitals", Neurology, 70, pp.1608~1613 (2008)
- Lim SS, "The cumulative incidence and trends of rare diseases in South Korea : a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015", Orphanet J Rare Dis, 14, pp.49~ (2019)
- Chen Y, "Population incidence of Guillain-Barré syndrome in parts of China : three large populations in Jiangsu province, 2008-2010", Eur J Neurol, 21, pp.124~129 (2014)
- Shui IM, "Guillain-Barré syndrome incidence in a large United States cohort(2000-2009)", Neuroepidemiology, 39, pp.109~115 (2012)
- Hense S, "Estimation of background incidence rates of Guillain-Barré syndrome in Germany-a retrospective cohort study with electronic healthcare data", Neuroepidemiology, 43, pp.244~252 (2014)
- Rivera-Lillo G, "Incidence of Guillain-Barré syndrome in Chile : a population-based study", J Peripher Nerv Syst, 21, pp.339~344 (2016)
- Delannoy A, "Guillain-Barré syndrome in France : a nationwide epidemiological analysis based on hospital discharge data(2008-2013)", J Peripher Nerv Syst, 22, pp.51~58 (2017)
- Winer JB, "Guillain-Barré syndrome", BMJ, 337, pp.a671~ (2008)
- Roodbol J, "Recognizing Guillain-Barre syndrome in preschool children", Neurology, 76, pp.807~810 (2011)
- Frenzen PD, "Economic cost of Guillain-Barré syndrome in the United States", Neurology, 71, pp.21~27 (2008)
- Espérou H, "Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. French Cooperative Group on plasma exchange in Guillain-Barré syndrome", Intensive Care Med, 26, pp.1094~1100 (2000)
- Funch D, "Algorithms for identification of Guillain-Barrésyndrome among adolescents in claims databases", Vaccine, 31, pp.2075~2079 (2013)